Lenalidomide [lenalidomid]
topical
144
- Terms
-
Revimid
-
2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
CC 5013
CC-5013
CC5013
IMiD3 Cpd
Revimid
Revlimid
Persistent link
https://www.medvik.cz/link/D000077269
Definition
A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.
- DUI
- D000077269 MeSH Browser
- CUI
- M0479831
- History note
- 2019 (2002)
- Public note
- 2019; LENALIDOMIDE was indexed under THALIDOMIDE/analogs & derivatives 2002-2018
Allowable subheadings
- AD
- administration & dosage 32
- AE
- adverse effects 21
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 1
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 1
- PD
- pharmacology 17
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 64
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records